UTime Limited Unveils Smartwatch Featuring Integrated Blood Pressure Monitoring

SHENZHEN, China, Oct. 28, 2025 — UTime Limited (Nasdaq: WTO), a global technology firm specializing in the design and development of mobile devices, today announced the introduction of a smartwatch featuring integrated blood pressure monitoring capabilities, thereby broadening its product line within the health technology sector.

This product employs the market-validated Oscillometric method, integrating a micro air pump and a high-precision pressure sensor to offer users a convenient blood pressure measurement experience. It has secured a China NMPA Class II Medical Device Registration Certificate (Registration Certificate No.: Guangdong Instrument Note No. 20162070928). Beyond its primary blood pressure monitoring function, the watch also provides multi-dimensional health metrics, including heart rate, blood oxygen saturation, sleep analysis, and tracking for various sports modes. The device’s design prioritizes both wearing comfort and everyday utility, incorporating interactive elements such as voice reminders.

Mr. Hengcong Qiu, Chief Executive Officer of UTime Limited, commented, “Our focus is on integrating practical health monitoring functionalities into mobile smart devices. The launch of this watch underscores our commitment to addressing the increasing user demand for personal health management.”

About UTime Limited

Listed on NASDAQ as WTO, UTime Limited specializes in the design, development, production, sales, and brand management of mobile devices across China and globally. The company aims to deliver cost-effective products, catering to a diverse customer base.

Safe Harbor Statement

This press release includes forward-looking statements as defined by Section 21E of the Securities Exchange Act of 1934, as amended. All statements that are not historical facts are considered forward-looking statements. These statements involve identified and unidentified risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from any future results, performances, or achievements expressed or implied by such forward-looking statements. For additional risk factors, please refer to UTime Limited’s Annual Report on Form 20-F and other SEC filings. Forward-looking statements are current only as of the date of this release. The Company is not obligated to publicly update or revise any forward-looking statements, whether due to new information, future events, or otherwise, except as required by applicable law.

Contact:

UTime Limited
7th Floor, Building 5A
Shenzhen Software Industry Base, Nanshan District
Shenzhen, People’s Republic of China 518061
Tel: (86) 755 86512266

Attachment